©2024 Stanford Medicine
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
Not Recruiting
Trial ID: NCT00532987
Purpose
Treatment of rectal cancer often consists of surgical resection of the tumor. Chemotherapy
and/or radiotherapy are frequently given before or after surgery. In this study, we wish to
learn if there are differences in the treatment effectiveness or in the quality of life of
patients based on their type of treatment (e.g. Radiotherapy and chemotherapy before or after
surgery). Information from this questionnaire collected from you and other patients may help
improve the quality of life of rectal cancer patients in the future. Medical information on
your tumor, treatment received, and side effects will be compiled and maintained in a
database to learn more about outcomes of treatment for rectal cancer.
Official Title
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
Stanford Investigator(s)
Scott G. Soltys, MD
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
Andrew A. Shelton, MD, FACS, FACRS
Clinical Professor, Surgery - General Surgery
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine
Eligibility
Inclusion Criteria:History of histologically-confirmed rectal cancer with treatment or
undergoing treatment at Stanford University Hospital.
Intervention(s):
behavioral: Questionnaire
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Moe Jalali
6507244023